<DOC>
	<DOCNO>NCT02838602</DOCNO>
	<brief_summary>This transnational prospective randomize trial compare definitive carbon ion therapy versus photon combine photon protontherapy standard treatment unresectable macroscopically uncompleted resect radioresistant tumor . Eligible tumor axial chordoma ( except base skull ) , adenoid cystic carcinoma head neck ( except trachea ) sarcoma site ( except chondrosarcoma skull base ) , non previously irradiate without pre-planned surgery chemotherapy clinical trial procedure . Randomization balance 1 1 . Patients experimental arm treat carbon ion center Europe patient standard arm treat France close participate radiotherapy center . An accrual 250 patient need absolute difference 20 % relapse free survival five year await . The main endpoint progression free survival five year . The trial support French program clinical research national health insurance . Two associated study carry : radiobiological one look radioresistance marker sarcomas biopsy , second one medico economics .</brief_summary>
	<brief_title>Randomized Carbon Ions v Standard Radiotherapy Radioresistant Tumors</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Adenoid Cystic</mesh_term>
	<mesh_term>Chordoma</mesh_term>
	<criteria>age ≥ 18 year No severe comorbidity , life expectancy 10 year Unresectable inoperable R2 resection tumor Radioresistant tumor accord limitative list follow : adenoid cystic carcinoma head neck ( larynx trachea exclude ) soft tissue sarcoma rhabdomyosarcoma retroperitoneal sarcoma osteosarcoma ( Ewing exclude ) chondrosarcoma ( except skull base ) axial skeleton chordoma ( except skull base ) angiosarcoma No skin involvement ECOG Performance Status ≤ 2 Karnovsky index ≥ 60 pregnancy possibility pregnancy treatment health insurance signature write informed consent validation randomization criterion : namely , carbon ion therapy indication assess medical team hadrontherapy center able treat within two month registration . previous irradiation tumor site active metastatic disease contraindication undergo radiation therapy Xray particle therapy plan surgery chemotherapy take place completion radiotherapy removable metallic material planning target volume history another cancer remission since less 5 year ( except situ cervix carcinoma basocellular skin cancer treat curative manner ) impossible followup .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>carbon ion therapy</keyword>
	<keyword>radiotherapy</keyword>
	<keyword>radioresistant tumor</keyword>
	<keyword>cancer</keyword>
	<keyword>randomize trial</keyword>
</DOC>